Skip to content
Medical Health Aged Care

What can your poo reveal about your heart health?

Monash University 2 mins read

Human and microbial proteins found in poo could help doctors detect a long-term risk of deadly cardiovascular conditions in otherwise healthy patients, avoiding the need for costly and invasive diagnostic procedures.

A new study from Monash University published today has linked the presence of certain faecal proteins to conditions like heart failure, and found they can be used as an early indicator of risk and outcomes.

This is a breakthrough in the early prevention and diagnosis of conditions that could otherwise go hidden until they become fatal.

Dr Francine Marques, a Monash Professor in the School of Biological Sciences and fellow at the National Health and Medical Research Council and National Heart Foundation, said the practice goes beyond traditional risk factors for heart disease.

“To have a non-invasive and affordable way to detect long-term risk of these diseases would be a game-changer,” Dr Marques said.

“Unless you have gastrointestinal diseases, you might never have tests that allow us to determine what is happening inside the human gut, as these are expensive and invasive.

“But if it were as simple as collecting a sample when you go to the toilet, more people would be in a position to find out their risk factors earlier and be in a position to take preventative steps.”

Researchers used a special piece of lab equipment called a mass spectrometer to develop a new method known as metaproteomics to look at the proteins contained in the faecal samples. 

They studied samples from 63 people from Melbourne and Shepparton who were not known to suffer from gastrointestinal or cardiovascular diseases and 27 samples from patients with heart failure. 

“We often sequence DNA to identify microbial genetic makeup, but this is the first time we have studied the proteins in faecal samples instead,” Dr Marques said. 

“Using this method, we identified both human and microbial proteins. 

“This is exciting as it basically worked as a non-invasive biopsy.” 

The identified proteins were compared with over 34 thousand samples from healthy people who were followed up over a period of 15-20 years. They found that gut proteins could predict the long-term risk of having a heart attack or a stroke.

“Outcomes remain poor after having a heart attack or stroke,” she said.

“Finding out our risk early means we can address the causes, like diet or lifestyle, and give ourselves the best chance of healthy ageing.”

Read the full paper at doi.org/10.1080/19490976.2024.2441356

MEDIA ENQUIRIES
Toni Brient
Media and Communications Manager, Monash University
M: +61 456 428 906
E: toni.brient@monash.edu 

GENERAL MEDIA ENQUIRIES
Monash Media
T: +61 3 9903 4840
E: media@monash.edu 

For more Monash media stories, visit our news and events site

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.